v3.26.1
Stockholders’ equity (Details Narrative) - USD ($)
 12 Months Ended
Dec. 16, 2025
Oct. 16, 2025
Sep. 29, 2025
Sep. 22, 2025
Sep. 15, 2025
Sep. 12, 2025
Jul. 18, 2025
Jul. 15, 2025
Mar. 26, 2025
Sep. 24, 2024
Aug. 12, 2024
Dec. 31, 2025
Dec. 31, 2024
Sep. 11, 2025
Apr. 24, 2024
Jun. 30, 2022
Class of Stock [Line Items]                                
Capital stock, shares authorized                       110,000,000        
Common stock, shares authorized                       100,000,000 100,000,000      
Undesignated preferred stock, shares authorized                       10,000,000 10,000,000      
Net proceeds                       $ 7,006,982 $ 3,608,555      
Value of stock issued over net assets                       4,718,311        
Value of stock issued                       6,714,512 3,608,555      
Additional paid in capital                       $ 49,967,549 $ 31,335,815   $ 148,703  
Restricted stock units, vested 62,500           62,500                  
Reserved issuance shares                               500,000
Outstanding shares percentage                               500.00%
Share-based compensation options to purchase common stock                       3,230,170 3,599,000      
Share-based compensation options, granted value                       $ 4,500,000 $ 2,790,000      
Option expiration period                       10 years 10 years      
Share based compensation                       $ 6,100,000 $ 1,900,000      
Weighted average grant-date fair values of options granted,                       $ 1.40 $ 0.77      
Unrecognized compensation costs                       $ 54,000        
Share-Based Payment Arrangement, Noncash Expense                       6,313,167 $ 1,920,805      
Proceeds from stock options exercised                       888,282      
Exercised options to purchase                       $ 888,282        
Common stock, par value                 $ 0.001     $ 0.0001 $ 0.0001      
Market capitalization $ 50,000,000           $ 25,000,000                  
Cash 50,000           50,000         $ 6,300,000        
Aggregate fair market value $ 90,625           $ 93,750                  
Chief Executive Officer [Member]                                
Class of Stock [Line Items]                                
Exercised options to purchase   613,595     300,000                      
Exercise price         $ 1.38                      
Proceeds from stock options exercised   $ 590,490                            
Chief Financial Officer [Member]                                
Class of Stock [Line Items]                                
Exercised options to purchase               126,061                
Share-Based Payment Arrangement, Noncash Expense                       $ 124,972        
Proceeds from stock options exercised               $ 151,023                
2022 Omnibus Plan [Member]                                
Class of Stock [Line Items]                                
Reserved issuance shares                       8,780,939        
Minimum [Member]                                
Class of Stock [Line Items]                                
Reserved issuance shares                           5,000,000    
Stock option exercise price         5.00                      
Maximum [Member]                                
Class of Stock [Line Items]                                
Restricted stock units, vested                 500,000              
Reserved issuance shares                           8,000,000    
Stock option exercise price         $ 6.50                      
Restricted Stock Units (RSUs) [Member]                                
Class of Stock [Line Items]                                
Restricted stock units, vested                       625,000        
Restricted stock units                       500,000      
Restricted Stock Units (RSUs) [Member] | 2022 Omnibus Incentive Plan [Member]                                
Class of Stock [Line Items]                                
Aggregate fair value of options                         $ 600,000      
Restricted stock vested percentage                         50.00%      
Stock price                         $ 1.19      
SKNY Pharmaceuticals Inc [Member]                                
Class of Stock [Line Items]                                
Net proceeds     $ 4,718,310                          
Issuance of shares     19,755,738                          
Share price     $ 1.33                          
Issuance of shares     $ 26,275,132                          
Value of stock issued over net assets     4,718,311                          
Value of stock issued     21,556,821                          
Deemed dividend     21,556,821                          
Increase to equity of common shares     $ 4,718,311                          
Stock price     $ 1.34                          
Common Stock [Member]                                
Class of Stock [Line Items]                                
Value of stock issued over net assets                       $ 1,976        
Value of stock issued                       $ 414 $ 178      
Exercised options to purchase       25,000   98,939           863,595 888,282      
Restricted stock units, vested                       625,000        
Exercised options to purchase       $ 29,750   $ 117,019           $ 86        
ATM Agreement [Member]                                
Class of Stock [Line Items]                                
Commission and other fees                       292,470 $ 130,000      
ATM Agreement [Member] | Common Stock [Member]                                
Class of Stock [Line Items]                                
Net proceeds                       $ 6,714,512 $ 3,600,000      
Issuance of shares                       4,133,402 1,779,967      
Share price                       $ 1.62 $ 1.65      
Undesignated Preferred Stock [Member]                                
Class of Stock [Line Items]                                
Undesignated preferred stock, shares authorized                       10,000,000        
Common Stock [Member] | ATM Agreement [Member]                                
Class of Stock [Line Items]                                
Net proceeds                   $ 75,000,000 $ 19,268,571